导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.67% | 166/354 |
| 近一周 | -1.26% | 53/362 |
| 近一月 | -2.61% | 134/362 |
| 近一季 | -0.19% | 105/362 |
| 近半年 | 11.82% | 145/358 |
| 近一年 | 9.24% | 157/349 |
| 近两年 | 27.63% | 187/314 |
| 近三年 | 55.72% | 89/246 |
| 成立以来 | 421.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.66% 166/360 |
12.48% 119/366 |
- - |
- - |
| 2025 | 13.64% 251/358 |
-4.40% 215/340 |
10.04% 141/348 |
6.56% 256/354 |
1.38% 85/358 |
| 2024 | 21.88% 82/329 |
8.88% 46/280 |
3.66% 132/310 |
3.55% 187/318 |
4.28% 91/329 |
| 2023 | 24.36% 56/275 |
4.82% 78/205 |
13.14% 59/230 |
-3.72% 90/262 |
8.90% 107/276 |
| 2022 | -11.85% 52/201 |
-5.32% 38/153 |
-11.27% 97/164 |
-0.16% 40/189 |
5.10% 132/202 |
| 2021 | 22.89% 35/150 |
6.24% 55/312 |
6.02% 119/328 |
0.57% 73/358 |
8.49% 43/151 |
| 2020 | 9.21% 44/103 |
-17.64% 204/280 |
19.25% 103/295 |
4.13% 106/299 |
6.79% 178/305 |
| 2019 | 29.91% 20/88 |
10.58% 113/258 |
5.83% 23/268 |
4.02% 38/253 |
6.72% 126/266 |
| 2018 | -1.24% 18/79 |
- - |
- - |
- - |
-13.27% 149/241 |
| 2017 | 12.16% 43/69 |
- - |
- - |
- - |
- - |
| 2016 | 16.57% 7/59 |
- - |
- - |
- - |
- - |
| 2015 | 6.65% 8/49 |
- - |
- - |
- - |
- - |
| 2014 | 12.80% 18/99 |
- - |
- - |
- - |
- - |
| 2013 | 26.72% 8/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 广发中证香港创新药ETF(QDII) | 1.2744 | 27.49% |
| 广发道琼斯石油指数美元现汇A | 0.4802 | 27.44% |
| 广发道琼斯石油指数美元现汇C | 0.4718 | 27.38% |
| 广发道琼斯石油指数(QDII-LOF)美元现汇E | 0.4729 | 27.33% |
| 广发道琼斯石油指数人民币A | 3.2498 | 26.68% |
| 广发道琼斯石油指数人民币C | 3.1927 | 26.58% |
| 广发道琼斯石油指数(QDII-LOF)人民币E | 3.2003 | 26.55% |
| 广发中证香港创新药ETF发起式联接(QDII)C | 1.3286 | 26.01% |
| 富国标普石油天然气勘探及生产精选行业ETF(QDII) | 1.4105 | 25.68% |
| 汇添富恒生生物科技ETF(QDII) | 1.1055 | 25.31% |
| 博时标普500ETF联接A VS. 建信富时100指数(QDII)人民币A(539003) |